| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, Alabama 35294-0005
The human papillomavirus type 18 E7 protein subverts the pRb/E2F pathway
to promote S-phase reentry by postmitotic, differentiated primary human
keratinocytes in support of viral DNA amplification. We prepared a
panel of HPV-18 E7 mutations in pRb binding or in casein kinase II
(CKII) phosphorylation. Our results showed that the ability of E7
binding to pRb correlated with the activation of DNA polymerase
or
cyclin E to various extents in differentiated keratinocytes of
organotypic cultures but was insufficient to induce the proliferating
cell nuclear antigen. Proteins mutated in the CKII recognition sequence
or in one or both serine substrates (S32 and S34) bound pRb in
vitro, but only those with negative charges at these two
residues induced proliferating cell nuclear antigen effectively.
Nevertheless, unscheduled cellular DNA synthesis occurred very
inefficiently relative to the wild-type E7, if at all. Thus, both pRb
binding and CKII phosphorylation of E7 are critical for activating
cellular genes essential for S-phase entry.
This article has been cited by other articles:
![]() |
N. J. Genovese, N. S. Banerjee, T. R. Broker, and L. T. Chow Casein Kinase II Motif-Dependent Phosphorylation of Human Papillomavirus E7 Protein Promotes p130 Degradation and S-Phase Induction in Differentiated Human Keratinocytes J. Virol., May 15, 2008; 82(10): 4862 - 4873. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Banerjee, N. J. Genovese, F. Noya, W.-M. Chien, T. R. Broker, and L. T. Chow Conditionally Activated E7 Proteins of High-Risk and Low-Risk Human Papillomaviruses Induce S Phase in Postmitotic, Differentiated Human Keratinocytes J. Virol., July 1, 2006; 80(13): 6517 - 6524. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Collins, T. Nakahara, A. Do, and P. F. Lambert Interactions with Pocket Proteins Contribute to the Role of Human Papillomavirus Type 16 E7 in the Papillomavirus Life Cycle J. Virol., December 1, 2005; 79(23): 14769 - 14780. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tugizov, J. Berline, R. Herrera, M. E. Penaranda, M. Nakagawa, and J. Palefsky Inhibition of Human Papillomavirus Type 16 E7 Phosphorylation by the S100 MRP-8/14 Protein Complex J. Virol., January 15, 2005; 79(2): 1099 - 1112. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Garner-Hamrick, J. M. Fostel, W.-M. Chien, N. S. Banerjee, L. T. Chow, T. R. Broker, and C. Fisher Global Effects of Human Papillomavirus Type 18 E6/E7 in an Organotypic Keratinocyte Culture System J. Virol., September 1, 2004; 78(17): 9041 - 9050. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Spitkovsky, S. P. Hehner, T. G. Hofmann, A. Moller, and M. L. Schmitz The Human Papillomavirus Oncoprotein E7 Attenuates NF-kappa B Activation by Targeting the Ikappa B Kinase Complex J. Biol. Chem., July 5, 2002; 277(28): 25576 - 25582. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Noya, W.-M. Chien, X. Wu, N. S. Banerjee, J. C. Kappes, T. R. Broker, and L. T. Chow The Promoter of the Human Proliferating Cell Nuclear Antigen Gene Is Not Sufficient for Cell Cycle-dependent Regulation in Organotypic Cultures of Keratinocytes J. Biol. Chem., May 3, 2002; 277(19): 17271 - 17280. [Abstract] [Full Text] [PDF] |
||||
![]() |
W.-M. Chien, F. Noya, H. M. Benedict-Hamilton, T. R. Broker, and L. T. Chow Alternative Fates of Keratinocytes Transduced by Human Papillomavirus Type 18 E7 during Squamous Differentiation J. Virol., March 15, 2002; 76(6): 2964 - 2972. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Noya, W.-M. Chien, T. R. Broker, and L. T. Chow p21cip1 Degradation in Differentiated Keratinocytes Is Abrogated by Costabilization with Cyclin E Induced by Human Papillomavirus E7 J. Virol., July 1, 2001; 75(13): 6121 - 6134. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |